1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Suvanza Pharma, LLC

Suvanza Pharma, LLC

SUVZ
Suvanza Pharma, LLCUS flagOther OTC
0.00
USD
- -
- -
1.01MMarket Cap

Income Statement (USD)

APIChatGPT
1993 Y
1994 Y
1995 Y
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
As of date
12/31/1993
12/31/1994
12/31/1995
12/31/1996
12/31/1997
12/31/1998
12/31/1999
12/31/2000
12/31/2001
12/31/2002
Sales/Revenue/Turnover
8
14
19
31
- -
- -
1
- -
- -
- -
+ Sales & Services Revenue
8
14
19
31
- -
- -
1
- -
- -
- -
- Cost of Revenue
4
8
11
20
- -
- -
1
- -
- -
- -
+ Cost of Goods & Services
4
8
11
20
- -
- -
1
- -
- -
- -
Gross Profit
4
6
8
11
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
3
4
6
8
1
1
6
10
22
17
+ Selling, General & Admin
3
4
4
6
- -
1
2
5
10
8
+ Research & Development
- -
- -
2
2
3
- -
1
5
7
4
+ Other Operating Expense
- -
- -
- -
- -
-2
- -
2
- -
5
5
Operating Income (Loss)
1
2
2
3
-1
-1
-6
-10
-22
-17
- Non-Operating (Income) Loss
- -
- -
- -
- -
-6
- -
1
-1
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
-6
- -
1
-1
- -
- -
Pretax Income
1
2
2
4
5
-1
-6
-9
-22
-17
- Income Tax Expense (Benefit)
- -
1
1
1
2
- -
5
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
1
1
1
2
- -
-1
-11
-9
-22
-17
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
-3
8
5
- -
-1
- -
+ Discontinued Operations
- -
- -
- -
- -
3
-8
-5
- -
1
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
-7
16
10
- -
-1
- -
Income (Loss) Incl. MI
1
1
1
2
3
-9
-16
-9
-21
-17
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
1
1
1
2
3
-9
-16
-9
-21
-17
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
1
1
1
2
3
-9
-16
-9
-21
-17
EBIT
1
2
2
3
-1
-1
-6
-10
-22
-17
EBITDA
1
2
2
4
-1
- -
-5
-10
-18
-13
EBITDA Margin (%)
17.07
14.71
10.82
12.75
-900
- -
-626.56
-991,800
-35,335.29
- -
EBITA
1
2
2
3
-1
-1
-6
-10
-22
-17
Gross Margin (%)
48.78
42.65
41.75
36.43
-400
- -
27.7
100
100
- -
Operating Margin (%)
15.85
13.24
8.76
10.26
-1,400
- -
-703.68
-1,036,300
-42,888.24
- -
Profit Margin (%)
10.98
8.09
7.22
7.33
3,200
- -
-2,012.83
-946,800
-40,905.88
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
32.67
23.18
15.86
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
- -
1
1
- -
4
4
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
42
51
37
47.2
75
-206.76
-314.43
-151.95
-251.08
-165.21
Basic EPS from Cont Ops
42
51
37
47.2
-4.69
-23.58
-211.19
-151.95
-259.19
-165.21
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
36
42
34
47.2
75
-206.76
-314.43
-151.95
-251.08
-165.21
Diluted EPS from Cont Ops
36
42
34
47.2
-4.69
-23.58
-211.19
-151.95
-259.19
-165.21

Balance Sheet (USD)

APIChatGPT
1993 Y
1994 Y
1995 Y
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
As of date
12/31/1993
12/31/1994
12/31/1995
12/31/1996
12/31/1997
12/31/1998
12/31/1999
12/31/2000
12/31/2001
12/31/2002
Total Current Assets
3
4
14
20
25
25
19
10
6
3
+ Cash, Cash Equivalents & STI
- -
- -
8
6
- -
- -
16
8
5
2
+ Cash & Cash Equivalents
- -
- -
8
6
- -
- -
16
8
5
2
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
2
2
3
10
17
2
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
10
17
2
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
2
2
3
- -
- -
- -
- -
- -
- -
- -
+ Inventories
1
1
2
4
7
7
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
1
1
2
4
7
7
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
1
16
2
2
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
1
1
2
1
- -
11
5
5
+ Property, Plant & Equip, Net
- -
1
1
1
2
1
- -
2
3
2
+ Property, Plant & Equip
- -
1
2
1
4
1
- -
2
3
2
- Accumulated Depreciation
- -
- -
1
- -
2
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
8
3
3
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
8
3
3
Total Assets
3
5
15
21
27
26
19
21
11
9
+ Payables & Accruals
1
1
1
5
3
9
3
3
1
2
+ Accounts Payable
1
1
1
3
3
7
- -
1
1
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
2
- -
1
3
3
1
- -
+ ST Debt
- -
- -
- -
- -
1
6
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
1
6
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
1
- -
- -
4
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
- -
- -
4
- -
- -
- -
- -
- -
Total Current Liabilities
2
2
2
5
8
14
3
3
1
2
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
2
2
2
5
8
14
3
3
1
2
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
- -
13
13
15
32
42
53
62
+ Common Stock
- -
- -
- -
13
13
15
32
42
53
62
+ Additional Paid in Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
1
2
1
3
6
-3
-19
-29
-50
-67
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
1
3
13
16
19
12
16
18
10
7
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
3
13
16
19
12
16
18
10
7
Total Liabilities & Equity
3
5
15
21
27
26
19
21
11
9
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
- -
-8
-6
1
5
-16
-8
-5
-2
Net Debt to Equity
- -
-18.52
-60.9
-40.32
3.63
46.4
-103.18
-43.53
-53.14
-35.32
Tangible Common Equity Ratio
44.83
58.7
88.08
74.78
71.75
44.51
82.45
84.82
87.81
78.64
Current Ratio
1.73
2.06
8.24
3.77
3.29
1.74
5.57
3.21
4.35
1.83
Cash Conversion Cycle
- -
2.87
25.16
77.3
51,803.94
- -
2,883.51
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
1993 Y
1994 Y
1995 Y
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
As of date
12/31/1993
12/31/1994
12/31/1995
12/31/1996
12/31/1997
12/31/1998
12/31/1999
12/31/2000
12/31/2001
12/31/2002
+ Net Income
1
1
1
2
3
-1
-11
-9
-22
-17
+ Depreciation & Amortization
- -
- -
- -
1
- -
1
1
- -
4
4
+ Non-Cash Items
- -
1
- -
- -
- -
-12
8
1
4
1
+ Stock-Based Compensation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
-4
5
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
- -
- -
- -
-8
3
1
4
1
+ Chg in Non-Cash Work Cap
-1
-1
-2
-4
-9
7
-5
- -
- -
- -
+ (Inc) Dec in Accts Receiv
-1
- -
-1
-7
-7
-2
2
- -
- -
- -
+ (Inc) Dec in Inventories
-1
- -
-2
-1
-3
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
- -
- -
4
1
3
-5
- -
-1
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
6
-2
- -
2
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
1
1
- -
-1
-6
-5
-7
-8
-13
-12
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-1
-2
- -
- -
-7
-1
-1
+ Acq of Fixed Prod Assets
- -
- -
-1
-1
-2
- -
- -
-2
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
-5
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
- -
1
10
6
12
11
+ Increase in Capital Stock
- -
- -
- -
- -
- -
1
10
6
12
11
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
15
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-1
-1
-2
- -
15
-7
-1
-1
+ Dividends Paid
-1
- -
-1
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
1
5
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
1
5
6
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
-6
- -
- -
- -
+ Other Financing Activities
- -
- -
9
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
-1
- -
8
- -
1
5
11
6
11
11
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
8
-2
-6
- -
18
-9
-2
-3
EBITDA
1
2
2
4
-1
- -
-5
-10
-18
-13
EBITDA Margin (%)
17.07
14.71
10.82
12.75
-900
- -
-626.56
-991,800
-35,335.29
- -
Free Cash Flow
1
1
-1
-2
-7
-5
-7
-15
-14
-13
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
1
1
-1
-2
-7
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
1
-1
-2
-6
-1
-7
-10
-14
-13
Free Cash Flow per Basic Share
28
32.45
-18.5
-36.14
-168.75
-122.81
-139.7
-243.36
-166.17
-130
Price/Free Cash Flow
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash Flow to Net Income
0.89
1.09
0.07
-0.42
-1.72
0.55
0.43
0.84
0.62
0.74
Capital Expenditures
- -
- -
-1
-1
-2
- -
- -
-7
-1
-1